MINDY JO WILLIAMSON: Open Payments
NPI 1376858761 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 45 payments from 15 companies in 2025. Trend: 2023 $1,215 · 2024 $3,153 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $208 |
| Medtronic, Inc. | 6 | $147 |
| Boston Scientific Corporation | 3 | $136 |
| ABIOMED | 4 | $114 |
| Lilly USA, LLC | 1 | $75 |
| Shockwave Medical, Inc | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $50 |
| Teleflex LLC | 2 | $43 |
| Kestra Medical Technology Services, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $37 |
Products named: LEQVIO, SYMPLICITY G3, CDS - MCT/CEM Monitoring, ZEPBOUND, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, PatientCare Link, AMVUTTRA, GUIDELINER.
Industry payments across MS — which companies pay providers there.
